Research programme: anti-HIV therapeutics - ViroCarbAlternative Names: GSL mimetics - Virocarb; VC-253; VC122 M4
Latest Information Update: 04 Nov 2016
At a glance
- Originator ViroCarb
- Class Antivirals; Small molecules
- Mechanism of Action HIV envelope protein gp120 modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical HIV infections
Most Recent Events
- 03 Nov 2016 Preclinical trials in HIV infections in Canada (unspecified route)